News Room
GSK on hunt for drug deals in China
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.GSK is…
Opinion: ‘Smidcap’ companies are becoming a big deal. Here’s a look at some of the best.
The stocks of long-neglected small companies are finally showing signs of life as the market rally broadens. But these tiny…
Turkish Airlines orders 200 Airbus aircraft worth tens of billions of dollars
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Turkish Airlines…
Opinion: Intel has big plans for AI-capable PCs, but that may take time to catch on
Intel Corp. is creating an ecosystem to foster the development and use of artificial intelligence on PCs, just as it…
The importance of the zero-star review
Stay informed with free updatesSimply sign up to the Life & Arts myFT Digest -- delivered directly to your inbox.I…
Why Amazon’s stock could be 2024’s biggest winner among major internet names
Amazon.com Inc. shares offer the most upside among large-capitalization internet companies going into next year, an analyst wrote Thursday. Piper…
The deals that show how lucrative private equity can be
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The writer…
Opinion: Presidential election years like 2024 are usually winners for U.S. stocks
As the 2024 U.S. presidential election approaches, many investors are worried about the impact that politics might have on their…